ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

Protein May Link Obesity To Cancer Aggressiveness

February 22, 2013

Three NCAB Members Say They Cannot Offer “Strong Endorsement” Of P-4 Trial.

June 15, 2007

Arthur Upton New Name In Director Race; Califano Meets With Prospects

May 6, 1977

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

NIH Consensus Conference Agenda, Registration Online.

September 1, 2000

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002